Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
Scheurer ME, Zhou R, Gilbert MR, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Youssef EF, Stieber VW, Komaki RR, Flickinger JC, Kenyon LC, Robins HI, Hunter GK, Crocker IR, Chao ST, Pugh SL, Armstrong TS. Scheurer ME, et al. Among authors: hunter gk. Neurooncol Adv. 2022 Oct 22;4(1):vdac152. doi: 10.1093/noajnl/vdac152. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36299794 Free PMC article.
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525.
Robins HI, Eickhoff J, Gilbert MR, Armstrong TS, Shi W, De Groot JF, Schultz CJ, Hunter GK, Valeinis E, Roach M 3rd, Youssef EF, Souhami L, Howard SP, Lieberman FS, Herman JG, Zhang P, Mehta MP. Robins HI, et al. Among authors: hunter gk. Neurooncol Pract. 2019 Dec;6(6):473-478. doi: 10.1093/nop/npz006. Epub 2019 Apr 6. Neurooncol Pract. 2019. PMID: 31832217 Free PMC article.
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
Patil N, Somasundaram E, Waite KA, Lathia JD, Machtay M, Gilbert MR, Connor JR, Rubin JB, Berens ME, Buerki RA, Choi S, Sloan AE, Penas-Prado M, Ashby LS, Blumenthal DT, Werner-Wasik M, Hunter GK, Flickinger JC, Wendland MM, Panet-Raymond V, Robins HI, Pugh SL, Mehta MP, Barnholtz-Sloan JS. Patil N, et al. Among authors: hunter gk. J Neurooncol. 2021 Dec;155(3):363-372. doi: 10.1007/s11060-021-03886-5. Epub 2021 Nov 10. J Neurooncol. 2021. PMID: 34761331 Free PMC article.
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M. Chang S, et al. Neuro Oncol. 2017 Feb 1;19(2):252-258. doi: 10.1093/neuonc/now236. Neuro Oncol. 2017. PMID: 27994066 Free PMC article. Clinical Trial.
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.
Blumenthal DT, Won M, Mehta MP, Gilbert MR, Brown PD, Bokstein F, Brachman DG, Werner-Wasik M, Hunter GK, Valeinis E, Hopkins K, Souhami L, Howard SP, Lieberman FS, Shrieve DC, Wendland MM, Robinson CG, Zhang P, Corn BW. Blumenthal DT, et al. Among authors: hunter gk. Neuro Oncol. 2018 Jun 18;20(7):966-974. doi: 10.1093/neuonc/noy017. Neuro Oncol. 2018. PMID: 29462493 Free PMC article. Clinical Trial.
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
Bell EH, Zhang P, Shaw EG, Buckner JC, Barger GR, Bullard DE, Mehta MP, Gilbert MR, Brown PD, Stelzer KJ, McElroy JP, Fleming JL, Timmers CD, Becker AP, Salavaggione AL, Liu Z, Aldape K, Brachman DG, Gertler SZ, Murtha AD, Schultz CJ, Johnson D, Laack NN, Hunter GK, Crocker IR, Won M, Chakravarti A. Bell EH, et al. Among authors: hunter gk. J Clin Oncol. 2020 Oct 10;38(29):3407-3417. doi: 10.1200/JCO.19.02983. Epub 2020 Jul 24. J Clin Oncol. 2020. PMID: 32706640 Free PMC article.
Treatment of five or more brain metastases with stereotactic radiosurgery.
Hunter GK, Suh JH, Reuther AM, Vogelbaum MA, Barnett GH, Angelov L, Weil RJ, Neyman G, Chao ST. Hunter GK, et al. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1394-8. doi: 10.1016/j.ijrobp.2011.10.026. Epub 2011 Dec 29. Int J Radiat Oncol Biol Phys. 2012. PMID: 22209150
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813.
Fleming JL, Pugh S, Bell EH, Chang SM, McElroy J, Becker A, Timmers CD, Shih HA, Ashby L, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD, Yung WA, Robins I, Werner-Wasik M, Chakravarti A. Fleming JL, et al. Among authors: hunter gk. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1399. doi: 10.1016/j.ijrobp.2020.09.021. Epub 2020 Nov 18. Int J Radiat Oncol Biol Phys. 2020. PMID: 33427658 No abstract available.
83 results